WASHINGTON (dpa-AFX) - While reporting financial results for the fourth quarter on Wednesday, Thermo Fisher Scientific Inc. (TMO) initiated adjusted earnings and revenue guidance for the full-year 2023.
Looking ahead to fiscal 2023, the company now projects adjusted earnings of $23.70 per share on revenues of $45.3 billion, with core organic revenue growth of 7 percent.
On average, analysts polled by Thomson Reuters are expecting the company to report earnings of $23.21 per share in revenues of $43.96 billion for the year. Analysts typically exclude one-time items.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
Copyright(c) 2023 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX